Study guide
2.5 Disciplinary Proceedings, Impairment & Current Monitoring
Mississippi MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Mississippi MPJE Overview
1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight
2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure
2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring
3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority
3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security
4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols
5 Chapter 5: Dispensing Controlled Substances & Prescription Processing
5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose
6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi
7 Chapter 7: Pharmacy Operations, Permits & Facilities
7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines
8 Chapter 8: Compounding Standards, Safety & Product Selection
8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications
9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations
9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps
2.5 Disciplinary Proceedings, Impairment & Current Monitoring
Key Takeaways Explain This Topic AI
Section 73-21-99 generally requires at least 30 days’ notice before a formal disciplinary hearing.
For an emergency summary suspension based on immediate danger, a formal hearing must be held within 20 days after the suspension.
A final Board order is appealed within 30 days to the chancery court of the licensee’s county of residence.
Grounds and sanctions come from the Pharmacy Practice Act and include fraud, unlawful practice, impairment, incompetence, drug-law violations, and other specified misconduct.
The Board’s current monitoring-services contractor is Professionals Healthcare Network, Inc. (PHN); do not rely on obsolete MARP identity or assume a universal five-year contract or automatic confidentiality.
Last updated: August 2026
Discipline, Due Process, and Impairment Monitoring
The Mississippi State Board of Pharmacy protects the public through investigation and administrative discipline. The controlling framework is in Miss. Code Ann. §§ 73-21-97 through 73-21-103 . A question may involve grounds for action, ordinary notice, emergency suspension, a final sanction, judicial review, or an impairment-monitoring arrangement. Keep those stages separate.
Grounds and available action
Section 73-21-97 authorizes action for grounds specified by statute. Important categories include fraud or deception in obtaining a credential; specified criminal or drug-law violations; practicing while impaired; addiction or misuse affecting safe practice; incompetence or gross negligence; unprofessional conduct; unlawful diversion, alteration, or record falsification; aiding unauthorized practice; violation of the Pharmacy Practice Act, controlled-substance law, or valid Board rules; and relevant discipline in another jurisdiction.
A charge must be tied to statutory authority and evidence. A complaint is not proof, and an investigation is not a final order. Depending on the violation and credential, authorized outcomes can include refusal, reprimand, restriction, probation, suspension, revocation, fines, costs, corrective education, monitoring, or other lawful conditions.
Ordinary hearing process
For a formal disciplinary hearing, § 73-21-99 generally requires at least 30 days' written notice . Notice identifies the matter and hearing so the respondent can prepare. At a contested hearing, the respondent may use counsel, present evidence, call and examine witnesses, and challenge evidence. The Board creates a record and issues an order. A negotiated consent order is binding only through proper approval; an informal conversation with an investigator is not final disposition.
Emergency summary action
When the Board finds that public health, safety, or welfare imperatively requires emergency action, it may summarily suspend a license or permit pending proceedings. This is the narrow exception to advance process. A formal hearing must be held within 20 days after summary suspension . “Promptly” without the 20-day rule is incomplete, while applying the ordinary 30-day advance-notice period to emergency action defeats the provision's purpose.
Judicial appeal
Under § 73-21-101 , an aggrieved licensee appeals a final Board order to the chancery court of the county of the licensee's residence within 30 days . Do not add the First Judicial District of Hinds County as an alternative when the current statute specifies the county of residence. An administrative appeal follows the statutory process; it is not a new federal jury trial.
Current impairment-monitoring provider
The Board's current contract award identifies Professionals Healthcare Network, Inc. (PHN) as contractor for pharmacist monitoring services, beginning December 1, 2025, with the award's stated term and options. Older materials directing candidates to the Mississippi Association of Recovering Pharmacists (MARP) are stale.
Impairment should trigger immediate patient-safety action and current Board or PHN instructions. Do not promise every self-referral is automatically confidential or non-disciplinary, every participant signs exactly a five-year contract, or every return-to-practice plan imposes an identical restriction list. Consequences depend on current program terms, facts, a treatment or monitoring agreement, and any Board order. Participation does not erase diversion, patient harm, falsification, or reporting duties.
A safe operational response is to remove an impaired person from patient-care and drug-access duties, protect patients and records, follow mandatory reporting obligations, and contact the current authorized program or Board channel. Never conceal discrepancies or alter records to help a colleague.
Exam framework
Ask whether the event is only a complaint, an ordinary formal case, or an immediate-danger case. Select the matching deadline: 30 days before the ordinary hearing , hearing within 20 days after emergency suspension , or appeal within 30 days . For recovery questions, use PHN as the current contractor and avoid guarantees not established by current official terms.
Process comparison
An ordinary case and an emergency case begin differently. For a documentation violation discovered during inspection, the Board can investigate and provide the ordinary 30-day hearing notice. If reliable evidence shows a pharmacist currently practicing while dangerously impaired, the Board may use summary authority to protect patients, followed by the formal hearing within 20 days. In either path, a final adverse order—not the complaint or investigator’s opinion—triggers the 30-day chancery-court appeal period.
An impaired colleague scenario also has two tracks: immediate workplace safety and longer-term monitoring. Remove the person from dispensing, secure controlled substances, assess affected prescriptions, preserve records, and follow reporting policy first. PHN evaluation or monitoring may follow, but treatment participation does not authorize concealment of a shortage or alteration of the audit trail.